Phase I/2 Study of PX-866 and Docetaxel in Patients with Solid Tumors (PX-866-002)

PrintE-mailPDF
Title Phase I/2 Study of PX-866 and Docetaxel in Patients with Solid Tumors (PX-866-002)
Contact AW
Principal Investigator Yujie Zhao, MD
Study Number 175510
Phase2
Summary

The purpose of the phase 2 part of the study is to find out whether PX-866 in combination with docetaxel is better than docetaxel alone at treating patients with locally advanced, recurrent, or metastatic non-small cell lung cancer or squamous cell cancer of the head and neck.

For more information about the clinical study go to Clinicaltrial.Gov

Cancer Talk Blog
Understanding Brain Tumors: The Basics
May is National Brain Tumor Awareness Month. To help you begin to understand this complex group of tumors, we have compiled some of the key facts, statistics and information below. Learn about the Neuro-oncology Center at Roswell Park or consult the links and sources below for more information. Brain Tumor Facts and Figures
Read more

Ask A Question

Do you have a cancer question you’d like RPCI cancer experts to address? Submit a topic for consideration.

New to RSS? Learn More

close